This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||
|
This page should not be speedy deleted because...
editThis page should not be speedily deleted because it provides information about a Biotechnology company that has a unique technology to create therapeutic bispecific antibodies, by engineering a region of immunoglobulins. It's currently the only company in the world that takes this approach to byspecific antibodies.